Emerging research suggest Retatru tide , a dual activator targeting both the gut-brain axis and another hormone, could provide a significant step forward for weight treatment. Early human tests have indicated considerable decreases in abdominal tissue, potentially outperforming current body composition treatments. However , more evaluation is neede